Global /Sweden /Healthcare /Medical Devices /IDLDX

IDL Diagnostics AB (publ)

IDLDX

• STO: IDLDX • Delayed

0.3140SEK -1.9%

0.0331 USD

As of 7 June 2026, IDL Diagnostics AB (publ) has a market cap of $7.86M USD, ranking #42508 globally and #677 in Sweden. It ranks #3764 in the Healthcare sector, and #790 in the Medical Devices industry.

Global Rank

42508

Country Rank

677

Sector Rank

3764

Industry Rank

790

Key Stats

Market Cap

$7.86MUSD

73.72M SEK

Enterprise Value

$5.32MUSD

50.38M SEK

Revenue (TTM)

$5.67MUSD

53.11M SEK

EBITDA (TTM)

-$998.94KUSD

-9.46M SEK

Net Income (TTM)

-$1.3MUSD

-12.15M SEK

EBITDA Margin

-18%

Profit Margin

-23%

PS Ratio

1.4

PB Ratio

0.5

Company Profile

Country (HQ)

Sweden

Sector

Healthcare

Industry

Medical Devices

CEO

Anders Hultman open_in_new

Employees

Founded

2000

Website

idldiagnostics.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-1.9%	-15%	9.8%	-11%	-13%	-11%	-45%	-52%	-95%

News

Markets

Exchange	Ticker	Price	Quotes
Nasdaq Stockholm (STO) MIC: XSTO PRIMARY	IDLDX AroCell AB ISIN: SE0003883990 Shares Out.: Shares Outstanding: 230.361M¹ Shares Float: 204.414M² TV: TradingView: OMXSTO: IDLDX SA: Stock Analysis: STO: IDLDX YF: Yahoo Finance: IDLDX.ST GF: Google Finance: STO: IDLDX BA: Barron's: IDLDX MS: Morningstar: XSTO: IDLDX	0.3140 SEK	TV: TradingView: OMXSTO: IDLDX SA: Stock Analysis: STO: IDLDX YF: Yahoo Finance: IDLDX.ST GF: Google Finance: STO: IDLDX BA: Barron's: IDLDX MS: Morningstar: XSTO: IDLDX
Frankfurt Stock Exchange (FRA) MIC: XFRA	80R AroCell AB ISIN: SE0003883990 TV: TradingView: FWB: 80R SA: Stock Analysis: FRA: 80R YF: Yahoo Finance: 80R.F GF: Google Finance: FRA: 80R BA: Barron's: 80R MS: Morningstar: XFRA: 80R	0.0168 EUR	TV: TradingView: FWB: 80R SA: Stock Analysis: FRA: 80R YF: Yahoo Finance: 80R.F GF: Google Finance: FRA: 80R BA: Barron's: 80R MS: Morningstar: XFRA: 80R

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About IDL Diagnostics AB (publ)

IDL Diagnostics AB (publ), a vitro diagnostics company, manufactures and sells IVD tests for oncological and bacterial diseases in Sweden. It offers UBC Rapid, a point-of-care test for diagnosis and monitoring of bladder cancer; AroCell TK 210 ELISA, a biomarker for tumor cells; and TUBEX TF, a vitro diagnostic test for detection of acute typhoid fever. Its vitro diagnostic biomarkers are used in breast, bladder, and prostate cancer therapies. The company was formerly known as AroCell AB (publ) and changed its name to IDL Diagnostics AB (publ) in May 2025. IDL Diagnostics AB (publ) was incorporated in 2000 and is based in Stockholm, Sweden.

Similar Companies

Industry: Medical Devices (Sweden)

Name	Market Cap (USD) diff.	PE	Country
Getinge AB (publ) STO: GETI-B	$5.59B 52.4B SEK 71K%	22.2	Sweden
S SciBase Holding AB STO: SCIB	$4.85B 45.5B SEK 62K%	-	Sweden
Elekta AB (publ) STO: EKTA-B	$2.23B 20.86B SEK 28K%	-	Sweden
Vitrolife AB (publ) STO: VITR	$1.59B 14.87B SEK 20K%	-	Sweden
Bonesupport Holding AB (publ) STO: BONEX	$1.53B 14.32B SEK 19K%	78.5	Sweden
Xvivo Perfusion AB (publ) STO: XVIVO	$907.38M 8.5B SEK 11K%	115.1	Sweden

Industry: Medical Devices (Global)

Name	Market Cap (USD) diff.	PE	Country
Thermo Fisher Scientific Inc. NYSE: TMO	$173.27B 2M%	25.8	United States
Intuitive Surgical, Inc. NASDAQ: ISRG	$160.73B 2M%	56.7	United States
Abbott Laboratories NYSE: ABT	$159.07B 2M%	25.6	United States
Danaher Corp. NYSE: DHR	$126.55B 2M%	34.7	United States
Stryker Corp. NYSE: SYK	$120.69B 2M%	38.3	United States
Medtronic plc NYSE: MDT	$101.9B 1M%	22.2	Ireland

chevron_leftBack